Related Experiment Videos

[Influence of surgery on survival in infective endocarditis]

Reda Arzanauskiene1, Rimantas Benetis, Petras Zabiela

  • 1Clinic of Cardiology, Kaunas University of Medicine Hospital, Eiveniu 2, 3007 Kaunas, Lithuania. aredar@hotmail.com

Insights

Surgery for infective endocarditis significantly improves heart failure symptoms. While hospital mortality remained similar, surgical intervention reduced overall mortality, especially for severe heart failure patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Infectious Diseases

Background:

  • Infective endocarditis (IE) is a serious infection affecting heart valves.
  • Management strategies include conservative treatment and surgical intervention.
  • The impact of surgery on survival and heart failure in IE patients requires detailed analysis.

Purpose of the Study:

  • To analyze the impact of surgical intervention for infective endocarditis on patient survival and heart failure status.
  • To compare outcomes between surgically treated and conservatively managed IE patients.

Main Methods:

  • A cohort of 131 patients with infective endocarditis observed between 1999-2001.
  • Patients were divided into surgical (63) and conservative (68) treatment groups.
  • Statistical analysis was used to compare heart failure severity, valve regurgitation, and mortality rates between groups.

Main Results:

  • Surgical patients presented with more severe heart failure and higher-grade aortic and mitral valve regurgitation (p<0.001).
  • Surgery led to significant improvement in heart failure symptoms (p=0.01).
  • Overall hospital mortality was 25.2% and did not differ significantly between groups. However, surgery reduced hospital mortality by 9.9% overall and 23.9% in NYHA III-IV patients (p=0.02) after accounting for complications.

Conclusions:

  • Surgical intervention for infective endocarditis, despite initial presentation with worse heart failure, leads to significant clinical improvement.
  • Surgery offers a survival benefit, particularly for patients with advanced heart failure (NYHA III-IV).
  • These findings support surgical consideration in select IE patients to improve outcomes.

Related Concept Videos